Quantessence Capital’s Hims & Hers Health HIMS Stock Holding History

Quantessence Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,547	Closed	-$825K	–	79
2025 Q3	$825K	Buy	+14,547	New	+$745K	0.26%	101

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantessence Capital's HIMS Position: Q4 2025 in Review

Quantessence Capital sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 14,547 shares — an estimated $825K sold.

Quantessence Capital first reported a position in HIMS in Q3 2025 and held it in 1 quarter. The position peaked at $825K in Q3 2025. 486 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

Quantessence Capital reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
Quantessence Capital sold 14,547 Hims & Hers Health shares in Q4 2025, an estimated $825K.
Quantessence Capital first reported a position in Hims & Hers Health in Q3 2025 and held it in 1 quarter.
Quantessence Capital's Hims & Hers Health position peaked at $825K in Q3 2025.
486 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Quantessence Capital's 13F filing for Q4 2025, filed 17 Feb 2026.